Who are Orasis Pharmaceuticals's investors?

Orasis Pharmaceuticals's investors include Arboretum Ventures, Maverick Ventures Israel, Visionary Ventures, Catalio Capital Management, Johnson & Johnson Innovation – JJDC, LifeSci Venture Partners, Sequoia Capital, Catalio Capital Management, LP.

Orasis Pharmaceuticals

Founded 2015 · 68 employees on LinkedIn · 8 known investors

Orasis is a pharmaceutical company developing drugs for the eye, operating in the ophthalmology and eyecare space. It is backed by healthcare-focused investors and announced a Series D financing in October 2024.

Biotech Healthtech Medical Devices

Investors · 8

Arboretum Ventures✓ verifiedAnn Arbor · $5M – $15M

Maverick Ventures Israel✓ verifiedTel Aviv · $2M – $5M

Visionary Ventures✓ verifiedNewport Beach · $5M – $15M

Catalio Capital Management✓ verifiedNew York

Johnson & Johnson Innovation – JJDC✓ verifiedNew Brunswick

LifeSci Venture Partners✓ verifiedNew York

Sequoia Capital✓ verifiedMenlo Park · $4.4M – $214M

Catalio Capital Management, LPNew York

Funding

SEC filings, press & company announcements

Undisclosed amountSeries CSep 2020
Bluestem Capital (lead), Visionary Ventures (lead), LifeSci Venture Partners, Maverick Ventures Israel, SBI (Japan) Innovation Fund, Sequoia Capital
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Orasis Pharmaceuticals Completes $78 Million Financing to Support Commercial Launch of Qlosi™ (pilocarpine hydrochloride ophthalmic solution) 0.4% - Orasisorasis-pharma.com · Oct 2024

Orasis Pharmaceuticals raises $30 million in financinghealio.com · Sep 2020

Orasis Raises $30 Million to Advance the Clinical Development of Novel Treatment for Presbyopia - Orasisorasis-pharma.com · Sep 2020

Orasis Pharmaceuticals Closes $13 Million Series B Financingorasis-pharma.com · Jun 2018

Frequently asked questions

What does Orasis Pharmaceuticals do?: Orasis is a pharmaceutical company developing drugs for the eye, operating in the ophthalmology and eyecare space. It is backed by healthcare-focused investors and announced a Series D financing in October 2024.
Who are Orasis Pharmaceuticals's investors?: Orasis Pharmaceuticals's investors include Arboretum Ventures, Maverick Ventures Israel, Visionary Ventures, Catalio Capital Management, Johnson & Johnson Innovation – JJDC, LifeSci Venture Partners, Sequoia Capital, Catalio Capital Management, LP.